Every published human trial of NMN has used between 250 mg and 1,250 mg a day, and the doses that measured an actual result sit between 250 and 900 mg. The largest dose-ranging study found the effect peaked at 600 mg. Bottles sold in the US span that whole range, so the number on the panel decides what you are buying.
Every Human NMN Trial Sits Between 250 and 1,250 mg a Day
NMN (nicotinamide mononucleotide) is a direct precursor to NAD+, the coenzyme cells use for energy metabolism and DNA repair. The supplement industry has settled on no standard dose, which is why two bottles on the same shelf can differ fivefold. The trials, by contrast, are narrow and countable.
| Daily NMN | Trial | What it measured | Length |
|---|---|---|---|
| 250 mg | Okabe 2022, Frontiers in Nutrition | Raised blood NAD+; no abnormalities in physiological or lab tests | 12 weeks |
| 250 mg (2 × 125 mg) | Katayoshi 2023, Scientific Reports | Raised serum nicotinamide; arterial stiffness trended down but missed significance | 12 weeks |
| 250 mg | Yoshino 2021, Science | Increased skeletal muscle insulin sensitivity in postmenopausal women with prediabetes | 10 weeks |
| 300 mg | Yi 2022, GeroScience | Blood NAD+ and six-minute walking distance both beat placebo | 60 days |
| 600 mg | Yi 2022, GeroScience | Highest blood NAD+ and longest walking distance of any arm | 60 days |
| 900 mg | Yi 2022, GeroScience | Safe and well tolerated; no better than 600 mg | 60 days |
| 1,250 mg | Fukamizu 2022, Scientific Reports | Safety endpoints only — no efficacy measures were taken | 4 weeks |
Read the right-hand column before the left one. Two of these doses were tested for what they do. One was tested only for whether it hurts. That distinction is what separates a dose you can reason about from a number a brand picked.
250 mg a Day: The Dose Three Trials Chose
Three separate research groups landed on 250 mg, and all three reported something. In a 12-week placebo-controlled trial in 30 healthy adults, 250 mg a day raised blood NAD+ with no abnormalities in physiological or laboratory testing. A second 12-week trial in 36 healthy middle-aged adults split the same 250 mg into two 125 mg capsules and found serum nicotinamide significantly higher than placebo, with pulse wave velocity — a measure of arterial stiffness — trending down without reaching statistical significance.
The most cited result at this dose ran 10 weeks in postmenopausal women with prediabetes and reported increased skeletal muscle insulin sensitivity, published in Science in 2021. That trial is narrow by design: one sex, one metabolic state, one outcome. It is evidence that 250 mg does something measurable in a specific group, not proof it does that thing for everyone.
Treat 250 mg as the floor. No published human trial has measured an outcome below it.
300 to 900 mg: Where More Stopped Doing More
The only trial that tested several doses side by side gave 80 healthy middle-aged adults placebo, 300 mg, 600 mg or 900 mg once daily for 60 days. Blood NAD+ rose significantly in all three NMN groups at day 30 and day 60, and six-minute walking distance beat placebo in all three. The interesting part is the shape of the curve rather than the fact of it: NAD+ was highest in the 600 mg and 900 mg groups, walking distance was longest in the 600 mg and 900 mg groups, and the authors concluded efficacy reached its highest point at 600 mg daily.
Going from 300 to 600 mg bought a measurable gain. Going from 600 to 900 mg mostly bought cost. That is the practical ceiling for anyone spending their own money — the band worth aiming at runs roughly 300 to 600 mg, and paying for more than 600 mg buys tolerance data rather than results.
1,250 mg a Day: A Safety Ceiling, Not a Target
High-dose NMN has been studied, and it was studied for the right reason. A randomized, double-blind, placebo-controlled trial gave 31 healthy adults aged 20 to 65 1,250 mg of NMN once daily for up to four weeks and found no changes beyond normal physiological variation across anthropometric, hematological, biochemical, urine and body-composition measures, with no severe adverse events.
That result answers "is a gram-plus dose harmful over a month" and nothing else. The trial measured no efficacy endpoints at all. A brand quoting it as support for a high-dose bottle is quoting a safety study as if it were a benefit study.
OUR VERDICT
Aim for 300 to 600 mg of NMN a day: every dose in that band beat placebo on both blood NAD+ and walking distance, and 600 mg was the peak. Below 250 mg you are under the lowest dose anyone has measured an outcome at; above 900 mg you are past the point where any trial recorded a benefit.
What the Labels in Front of You Actually Print
A dose recommendation is only useful if the bottle tells you what is in it. The two NMN lines on this store handle that differently, and the difference is worth knowing before you check out.
AgeAura Pure NMN + TMG NAD+ Complex ($69.95) prints its whole panel on the product page. Each daily serving is two capsules and contains 500 mg NMN, 250 mg TMG, 150 mg quercetin, 100 mg trans-resveratrol and 50 mg apigenin. The bottle front carries 60 capsules and 30 servings, which matches: two capsules a day, thirty days, $2.33 a day. At 500 mg it lands between the 300 mg and 600 mg arms of the dose-ranging trial — inside the band, near the top of it.
The simpler two-ingredient AgeAura Pure NMN + TMG ($59.95) is one capsule daily and states that the dose printed on the label is the dose in the capsule — but the page does not print that number. You cannot check it against this article without asking. If that listing is the one you want, email support@wellnessnest.co for the per-capsule NMN amount before you buy, and hold us to giving you a figure. A supplement page that names a dose should show it.
That is the check to run on any NMN bottle sold in the US, ours included: find the milligrams of NMN per serving, find how many capsules make a serving, and multiply. Brands that lead with capsule count instead of milligrams are usually hoping you will not.
How to Choose Your Own NMN Dose in the US
Four questions settle it faster than another round of research.
✅ How many milligrams of NMN per serving — not per bottle, not per capsule?
✅ How many capsules make that serving, and can you take them daily without thinking about it?
✅ Does the daily total land between 300 and 600 mg, where the trials measured gains?
✅ What does one day cost, and are you still willing to pay it in month three?
The last question decides more outcomes than the dose does. Every trial above ran between four weeks and twelve weeks of uninterrupted daily dosing, and NAD+ measurements were taken on that schedule. A 600 mg bottle you abandon in week three is worth less than a 500 mg bottle you finish. If you want the companion decisions — whether to take it with food or on an empty stomach, and why TMG rides along — we covered when to take NMN and why NMN is paired with TMG separately.
One caution that applies to every dose in this article: NMN is regulated in the United States as a dietary supplement, so these are structure and function statements, not treatment claims. If you take prescription medication, are pregnant or nursing, or are managing a diagnosed metabolic condition, settle your dose with your own physician rather than with a comparison table.
Where to Buy NMN in the United States
Wellness Nest ships NMN nationwide from the US, and the two AgeAura formulas run $59.95 to $69.95 for a bottle. The five-ingredient NAD+ Complex is the one whose full per-serving panel is published, so it is the one you can check against the doses in this article.
See the full 500 mg per-serving panel →
Browse the rest of the longevity line in the AgeAura collection, or compare it against what other American buyers reach for most in the best sellers collection. Both pages list current US pricing, and a bottle at either price works out between roughly $1.20 and $2.33 a day depending on serving size — worth doing that arithmetic before a subscription rather than after.
Frequently Asked Questions
How much NMN should I take per day?
Between 300 and 600 mg a day matches the range where trials measured results. The 60-day dose-ranging trial found 300, 600 and 900 mg all beat placebo on blood NAD+ and six-minute walking distance, with efficacy highest at 600 mg. Below 250 mg you are under the lowest dose any published human trial has measured an outcome at.
Is 500 mg of NMN a day too much?
No. It sits between the 300 mg and 600 mg arms of the dose-ranging trial, both of which were safe and both of which beat placebo. Doses far higher have been tested for safety: 1,250 mg daily for four weeks produced no changes beyond normal physiological variation in 31 healthy adults aged 20 to 65.
How long does NMN take to work?
The trials measured on a scale of weeks, not days. Blood NAD+ was significantly raised by day 30 of daily dosing, and the trials reporting functional changes ran 10 to 12 weeks. Judge a bottle at the end of it, not in the first fortnight.
Should I take NMN once a day or split the dose?
Both appear in the literature. Three trials used a single daily dose; one split 250 mg into two 125 mg capsules and still raised serum nicotinamide against placebo. No trial has compared the two schedules head to head, so pick whichever you will actually keep up.
Where can I buy NMN in the US?
Wellness Nest ships both AgeAura NMN formulas across the United States, priced $59.95 to $69.95 per bottle. The NAD+ Complex publishes its full 500 mg per-serving panel on the product page; the whole longevity line sits in the AgeAura collection.
Do I need TMG with NMN?
TMG is a methyl donor, and the case for pairing it rests on methylation demand rather than on a trial of the combination — no dose-finding study of NMN plus TMG exists. The NAD+ Complex includes 250 mg per serving alongside its 500 mg of NMN. We covered the reasoning in full in NMN and TMG together.
About the Author
Dr. Marcus Hale — Dr. Marcus Hale is the resident health researcher behind Wellness Nest's editorial team, translating peer-reviewed sports-nutrition and longevity research into practical daily guidance for US readers.
